Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
MiNK Therapeutics, Inc. (INKT) had Cash Flow from Financial Activities of $13.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.89M |
|
-- |
|
-- |
|
$3.18M |
|
$-3.18M |
|
$0.30M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-3.18M |
|
$-3.14M |
|
4.44M |
|
4.44M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$14.53M |
|
$0.43M |
|
$0.43M |
|
$14.96M |
|
$13.43M |
|
-- |
|
$15.04M |
|
$28.48M |
|
$-13.51M |
|
$-13.51M |
|
$-13.51M |
|
4.60M |
|
| Cash Flow Statement Financials | |
$-3.85M |
|
-- |
|
|
Cash Flow from Financial Activities |
$13.55M |
$4.58M |
|
$14.28M |
|
$9.70M |
|
$2.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.08 |
|
-- |
|
-- |
|
-- |
|
-0.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.37% |
|
21.37% |
|
-19.30% |
|
21.37% |
|
$-2.94 |
|
$-0.87 |
|
$-0.87 |
|